Skip to main content
. 2010 Jul 1;21(13):2102–2116. doi: 10.1091/mbc.E10-02-0098

Figure 1.

Figure 1.

Ubr1 functions in the degradation of newly synthesized protein kinases when Hsp90 is inhibited with geldanamycin. (A) Pulse-chase analysis of HA-Tpk2 in wild-type cells treated with geldanamycin (GA; 50 μM) and the proteasome inhibitor, MG132 (100 μM) or solvent alone. (B) Pulse-chase analysis of HA-tagged Tpk2 in wild-type and ubr1Δ cells treated with GA. Chase times shown in minutes. (C) Graph of HA-Tpk2 degradation (n = 3; error bars, ±SE).